The Texas Heart Institute
The Texas Heart Institute is an independent, nonprofit organization that is improving cardiovascular health through trailblazing research, thought leadership, education, and patient care. Our vision is to bring the future of cardiovascular care to life. Today THI is led by Dr. Joseph Rogers, an internationally recognized cardiologist and highly published ...
read more ↘
read more ↘
2020
The Texas Heart Institute
Menopause vs. Manopause: Why Have the CVD Rates of Death Been on the Decline? Is Menapause a Risk Factor?
FEATURING
Stephanie Coulter
- 233 views
- April 20, 2021
- 1
The Texas Heart Institute
Male Menopause: Does Testosterone Therapy Increase Cardiovascular Risk?
FEATURING
Stephanie Coulter
- 587 views
- April 20, 2021
The Texas Heart Institute
Status of Women Cardiovascular Surgeons in the US Today
FEATURING
Ourania Preventza
- 6 views
- April 9, 2021
The Texas Heart Institute
Venous Arterialisation as Treatment for CLTI: What Are the Two Different Ways to Perform the Procedure?
FEATURING
Miguel Montero-Baker
- 1,839 views
- April 20, 2021
- 9
The Texas Heart Institute
Cryptogenic Stroke: Is PFO Implicated?
FEATURING
R. David Fish
- 8 views
- April 20, 2021
The Texas Heart Institute
Cryptogenic Stroke: When Do We Close A PFO?
FEATURING
R. David Fish
- 18 views
- April 20, 2021
The Texas Heart Institute
Cardio-Oncology: Who Are the Cancer Patients at Risk For Developing Cardiac Dysfunction?
FEATURING
Juan Carlos Plana
- 6 views
- April 20, 2021
The Texas Heart Institute
What's New in Atrial Fibrillation
FEATURING
Mehdi Razavi
- 22 views
- April 20, 2021
The Texas Heart Institute
Updates on the CABANA and AMAZE Trials: What Is the Efficacy of Catheter Ablation vs. Antiarrhythmic Drug Therapy Among Patients With Atrial Fibrillation? Does the Left Atrial Appendage Occluder Help in the Management of Permanent A-Fib?
FEATURING
Mehdi Razavi
- 932 views
- April 20, 2021
- 3
The Texas Heart Institute
CAD Assessment: What Are the Risk Formulas? What Are the Associated Tests Used to Assess Risk?
FEATURING
Eduardo Hernandez
- 2 views
- April 22, 2021
The Texas Heart Institute
Coronary Artery Disease and the Use of Aspirin: What Is the Efficacy of Use for Primary Prevention?
FEATURING
Eduardo Hernandez
- 982 views
- April 22, 2021
- 4
The Texas Heart Institute
Triglyceride Reduction for CV Risk: What Do We Know About the Association With ASCVD Events?
FEATURING
Salim Virani
- 11 views
- April 22, 2021
The Texas Heart Institute
Insights into Triglyceride Reduction: What Do the Treatment Guidelines Tell Us and Why?
FEATURING
Salim Virani
- 398 views
- April 22, 2021
- 2
The Texas Heart Institute
Triglyceride Lowering Therapies: What Have We Recently Learned? What Is Coming Down the Pipeline?
FEATURING
Salim Virani
- 1,041 views
- April 22, 2021
- 6
The Texas Heart Institute
Heart Failure in Women: What Is the Epidemiology?
FEATURING
Jerry D. Estep
- 9 views
- April 20, 2021
The Texas Heart Institute
Women and Heart Failure: What Does the Evidence Show for Differences Between the Sexes?
FEATURING
Jerry D. Estep
- 14 views
- April 20, 2021
The Texas Heart Institute
Heart Failure and Women: What Are the Devices and Sex Specific Medications?
FEATURING
Jerry D. Estep
- 315 views
- April 20, 2021
- 3
The Texas Heart Institute
The Latest Advances in TAVR: How to Significantly Reduce Conduction Disturbances?
FEATURING
Zvonimir Krajcer,
Hemal Gada
- 413 views
- April 9, 2021
- 3
The Texas Heart Institute
Current Status of TAVR: How Has Site Preference Affected Outcomes? What Are the Unmet Needs?
FEATURING
Zvonimir Krajcer,
Vinod Thourani
- 220 views
- April 9, 2021
- 3